Weight loss, in the context of medicine or health or physical fitness, is a reduction of the total body weight, due to a mean loss of fluid, body fat or adipose tissue and/or lean mass, namely bone mineral deposits, muscle, tendon and other connective tissue.
At the age of 18, most young women are embarking on adulthood without a care in the world?health included. But experts at UC say that shouldn?t always be the case. – University of Cincinnati UC experts urge women to watch for warning signs associated with heart disease, a condition that is becoming more common, especially among women.
Most experts agree thyroid function tests are generally unnecessary in an overweight child if he/she has normal linear growth and no other symptoms of hypothyroidism. The results of this study support this. – Children treated for hypothyroidism aren’t likely to drop pounds with treatment for the condition says a new study in the Journal of Pediatrics. The study is the first to examine the link between hypothyroidism treatment and weight loss in pediatric patients.
Gastric inhibitory polypeptide (GIP) hormone in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes. – A new study finds that a chemical found in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes in an animal model. The hormone is gastric inhibitory polypeptide (GIP) receptor blockade.
A new CSIRO study has found that overweight and obese men can lose weight effectively and safely on a high protein diet.
– Presenting the results of the study at the Nutrition Society Conference in Auckland, NZ, CSIRO dietitian Dr Manny Noakes said that the study suggests it is easier than previously thought for men to take action to lose weight.
Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. – The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.
